Received Jan 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (HIBERIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | J7JF7 | — |
inappropriate reconstitution technique; inappropriate reconstitution technique; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 8-month-old female patient who received Hib (Hiberix) (batch number J7JF7, expiry date 15-JUL-2026) for prophylaxis. On an unknown date, the patient received Hiberix. On an unknown date, an unknown time after receiving Hiberix, the patient experienced inappropriate dose of vaccine administered (Verbatim: inappropriate reconstitution technique) and inappropriate preparation of medication (Verbatim: inappropriate reconstitution technique). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 06-JAN-2026 The nurse reported that the Hiberix was maladministered to three patients possibly, diluent only was administered. Three patients could have been impacted but they did not know who exactly received the diluent only. This was 1 of the 3 cases, reported by the same reporter.; Sender's Comments: US-GSK-US2026001200:Same reporter US-GSK-US2026001197:Same reporter